[go: up one dir, main page]

EP4262799A4 - HOMOGENEOUS COMPOSITIONS FOR PROPIVERINE HCL FORMULATIONS - Google Patents

HOMOGENEOUS COMPOSITIONS FOR PROPIVERINE HCL FORMULATIONS Download PDF

Info

Publication number
EP4262799A4
EP4262799A4 EP20966117.2A EP20966117A EP4262799A4 EP 4262799 A4 EP4262799 A4 EP 4262799A4 EP 20966117 A EP20966117 A EP 20966117A EP 4262799 A4 EP4262799 A4 EP 4262799A4
Authority
EP
European Patent Office
Prior art keywords
homogeneous compositions
hcl formulations
propiverine
propiverine hcl
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20966117.2A
Other languages
German (de)
French (fr)
Other versions
EP4262799A1 (en
Inventor
Erol KIRESEPI
Ersin Yildirim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santa Farma Ilac Sanayi AS
Original Assignee
Santa Farma Ilac Sanayi AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santa Farma Ilac Sanayi AS filed Critical Santa Farma Ilac Sanayi AS
Publication of EP4262799A1 publication Critical patent/EP4262799A1/en
Publication of EP4262799A4 publication Critical patent/EP4262799A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20966117.2A 2020-12-18 2020-12-18 HOMOGENEOUS COMPOSITIONS FOR PROPIVERINE HCL FORMULATIONS Pending EP4262799A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2020/051331 WO2022132066A1 (en) 2020-12-18 2020-12-18 Homogenous compositions of propiverine hci formulations

Publications (2)

Publication Number Publication Date
EP4262799A1 EP4262799A1 (en) 2023-10-25
EP4262799A4 true EP4262799A4 (en) 2024-09-25

Family

ID=82059774

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20966117.2A Pending EP4262799A4 (en) 2020-12-18 2020-12-18 HOMOGENEOUS COMPOSITIONS FOR PROPIVERINE HCL FORMULATIONS

Country Status (2)

Country Link
EP (1) EP4262799A4 (en)
WO (1) WO2022132066A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024117997A1 (en) * 2022-11-30 2024-06-06 Santa Farma Ilac Sanayii A.S. Pharmaceutical composition comprising propiverine hydrochlorde in matrix form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102218063A (en) * 2011-04-12 2011-10-19 贵州神奇制药有限公司 Method for preparing propiverine hydrochloride medicaments, and product and detection method thereof
WO2017026950A1 (en) * 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
EP2276472B1 (en) * 2008-04-15 2018-11-21 Adare Pharmaceuticals, Inc. Compositions comprising weakly basic drugs and controlled-release dosage forms
WO2020101586A1 (en) * 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
CN102579404A (en) * 2012-01-17 2012-07-18 广州科的信医药技术有限公司 Sustained-release capsule containing propiverine hydrochloride and preparation method of sustained-release capsule

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2276472B1 (en) * 2008-04-15 2018-11-21 Adare Pharmaceuticals, Inc. Compositions comprising weakly basic drugs and controlled-release dosage forms
CN102218063A (en) * 2011-04-12 2011-10-19 贵州神奇制药有限公司 Method for preparing propiverine hydrochloride medicaments, and product and detection method thereof
WO2017026950A1 (en) * 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
WO2020101586A1 (en) * 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022132066A1 *

Also Published As

Publication number Publication date
EP4262799A1 (en) 2023-10-25
WO2022132066A1 (en) 2022-06-23

Similar Documents

Publication Publication Date Title
EP4094582A4 (en) COMPOSITION
EP4227390A4 (en) COOLANT-CONTAINING COMPOSITION
EP4148096A4 (en) COMPOSITION
EP3442488A4 (en) COMPOSITIONS FOR TOPICAL APPLICATION OF COMPOUNDS
DK3924443T3 (en) Compositions
EP4328279A4 (en) COMPOSITION
EP3788012A4 (en) COMPOSITIONS TO CONTROL PHYTOPLANCTON CONTAMINATION
EP4279545A4 (en) COMPOSITION
EP4112065A4 (en) ANTI-TUMOOR COMPOSITION
EP3936494C0 (en) BIOSTIMULANT COMPOSITION FOR PLANTS
EP3999039A4 (en) PRETOMANID COMPOSITIONS
EP4313320A4 (en) ANTI-PERSPECTIVE COMPOSITION
EP4279562A4 (en) COMPOSITION FOR POLISHING
EP4281046C0 (en) NALTREXON COMPOSITIONS
EP4262799A4 (en) HOMOGENEOUS COMPOSITIONS FOR PROPIVERINE HCL FORMULATIONS
EP3818102A4 (en) NEW COMPOSITIONS FOR BITTERS
EP4372077A4 (en) AUTOPHAGY-ACTIVATING COMPOSITION
EP4256012C0 (en) COMPOSITION
EP4234670A4 (en) DETERGENT COMPOSITION
EP4291042C0 (en) OAT-DERIVED COMPOSITION
EP4454715A4 (en) COMPOSITION
EP4403170A4 (en) Caryopylene-containing composition
EP4393305A4 (en) COMPOSITION
EP4337752C0 (en) COMPOSITION
EP4330366C0 (en) COMPOSITION

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230511

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240822

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/48 20060101ALI20240817BHEP

Ipc: A61K 9/20 20060101ALI20240817BHEP

Ipc: A61K 9/16 20060101ALI20240817BHEP

Ipc: A61P 13/10 20060101ALI20240817BHEP

Ipc: A61P 13/00 20060101ALI20240817BHEP

Ipc: A61K 31/445 20060101AFI20240817BHEP